Remote Monitoring and Optimization of Heart Failure Therapy
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 800 participants.
Also called NCT07622472
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 800 participants
- Sponsor
- Registry
-
NCT07622472
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France, Germany, Italy, Netherlands, Poland, Spain, Sweden, Switzerland, United Kingdom
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07622472. Randomized; no masking; primary purpose treatment. Start 2026-10-01 (anticipated); primary completion 2028-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Remote Monitoring and Optimization of Heart Failure Therapy
- Acronym
- REMODEL-HF
- Condition
- Heart Failure
- Intervention (Device)
- Wearable Monitoring Device for Heart Failure
- Lead sponsor
- Zoll Medical Corporation
Record details
- Record id
cardio:ct-nct07622472- Content hash
50087bec49178259600dd3d7d19084eed6034049cfb972d09d82eb888ef8ebd6